These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12324981)

  • 1. Diabetes trends in the USA.
    Skyler JS; Oddo C
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S21-6. PubMed ID: 12324981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes in Mexico--a serious and growing problem.
    Phillips M; Salmerón J
    World Health Stat Q; 1992; 45(4):338-46. PubMed ID: 1299074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of diabetes in Latin America and the Caribbean.
    Barceló A; Aedo C; Rajpathak S; Robles S
    Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
    Stuart B; Shaffer TJ; Simoni-Wastila LJ; Zuckerman IH; Quinn CC
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growing burden of diabetes mellitus in the US elderly population.
    Sloan FA; Bethel MA; Ruiz D; Shea AM; Feinglos MN
    Arch Intern Med; 2008 Jan; 168(2):192-9; discussion 199. PubMed ID: 18227367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
    Patel H; Srishanmuganathan J; Car J; Majeed A
    J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
    Aquilante CL; Zhang W; McCollum M
    Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004.
    Rathmann W; Haastert B; Icks A; Giani G
    Diabetes Care; 2007 Apr; 30(4):848-53. PubMed ID: 17392545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The direct medical cost of diabetes in Israel.
    Chodick G; Heymann AD; Wood F; Kokia E
    Eur J Health Econ; 2005 Jun; 6(2):166-71. PubMed ID: 15690168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The public health burden of diabetes: a comprehensive review.
    Disdier-Flores OM; Rodríguez-Lugo LA; Pérez-Perdomo R; Pérez-Cardona CM
    P R Health Sci J; 2001 Jun; 20(2):123-30. PubMed ID: 11561471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations in assessing effectiveness and costs of diabetes care: lessons from DARTS.
    Morris AD
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S32-5. PubMed ID: 12324983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving oral pharmacologic treatment and management of type 2 diabetes.
    Dailey GE
    Manag Care; 2004 Feb; 13(2):41-7. PubMed ID: 15004930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.